GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
U

Univec UNVC · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

-17.74%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2025

Revenue

$85,014

FY2019FY2025

Net income

−$1.2m

FY2019FY2025

Free cash flow

−$15.6m

FY2019FY2025

Shareholders' equity

−$17.7m

FY2019FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Revenue$85,014$36,808$21,044$33,165$53,680$14,508$14,508
Gross profit$8,062−$4,110−$4,456−$3,579$21,102$1,116$1,116
Operating income−$1.2m−$1.2m−$2.6m−$2.7m−$1.3m−$1.2m−$1.1m
Net income−$1.2m−$1.2m−$2.6m−$2.7m−$1.3m−$1.2m−$1.1m
Diluted earnings per share-0.00-0.00-0.00-0.00-0.00-0.00-0.00

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Total assets$31,811$34,403$32,298$1.4m$2.8m——
Cash and short-term investments————$341——
Total liabilities$17.7m$16.3m$15.1m$13.8m$14.4m$13.1m$12.0m
Debt$1.4m$1.2m$1.2m$1.1m$1.1m$1.0m$1.0m
Shareholders' equity−$17.7m−$16.3m−$15.1m−$12.5m−$11.5m−$13.1m−$12.0m
Shares outstanding2,523m2,523m2,523m2,523m2,340m2,523m2,523m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Cash from operations−$15.6m−$55,005−$55,108−$1.8m−$4.0m−$9,452−$9,671
Capital spending−$3−$5−$1—−$34,470——
Free cash flow−$15.6m−$55,010−$55,109−$1.8m−$4.0m−$9,452−$9,671

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue$21,025$19,250$17,500$33,389$17,875$16,250$14,160$5,400
Gross profit$1,885$1,657$1,500$9,634−$764−$812−$1,000−$1,135
Operating income−$309,656−$302,753−$350,939−$312,268−$303,146−$305,151−$304,302−$304,236
Net income−$311,471−$306,323−$284,334−$314,295−$307,285−$309,460−$307,461−$309,756
Diluted earnings per share-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00
Cash from operations——−$15.0m—————
Total assets$32,394$32,098$31,811$49,195$35,176$35,030$34,403$28,370
Debt$11,820$16,407$18,873$23,503$24,199$23,254$22,205$21,021
Shareholders' equity−$18.3m−$18.0m−$17.7m−$17.2m−$16.9m−$16.6m−$16.3m−$16.0m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue36.9%42.4%-40.8%
Operating income-23.2%0.8%-2.1%
Net income-23.0%0.8%-2.4%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin3.2%-2.3%7.4%2.1%
Operating margin-1986.1%-4345.4%-4150.6%-49.5%
Net margin-2014.1%-4383.8%-4186.0%-55.6%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Price to earnings-5.2-4.3-2.4-4.7-43.3-23.3-16.2
Price to sales74.2143.9290.4376.1———

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return-4%18%-57%-81%160%58%223%700%1300%0%

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.